Imaging agents for detecting neurological dysfunction
    12.
    发明授权
    Imaging agents for detecting neurological dysfunction 有权
    用于检测神经功能障碍的成像剂

    公开(公告)号:US08318132B2

    公开(公告)日:2012-11-27

    申请号:US12372717

    申请日:2009-02-17

    IPC分类号: A61K51/00 A61M36/14

    CPC分类号: C07B59/002

    摘要: Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled flavones, coumarins, carbazoles, quinolinones, chromenones, imidazoles and triazoles derivatives, allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease.

    摘要翻译: 本文公开了在哺乳动物中诊断阿尔茨海默病或其倾向的化合物和方法,所述方法包括向哺乳动物施用诊断有效量的放射性标记的化合物,其中所述化合物选自放射性标记的黄酮,香豆素,咔唑 ,喹啉酮,色烯酮,咪唑和三唑衍生物,使化合物分布到脑组织中,并使脑组织成像,其中与正常对照结合水平相比,化合物与脑组织的结合增加指示哺乳动物 患有或有发生阿尔茨海默病的风险。